Morgan Stanley’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.13M | Sell |
|
|||||
|
2025
Q1 | $3.08M | Buy |
|
|||||
|
2024
Q4 | $1.96M | Buy |
|
|||||
|
2024
Q3 | $4.46M | Buy |
|
|||||
|
2024
Q2 | $4.29M | Sell |
|
|||||
|
2024
Q1 | $13.2M | Sell |
|
|||||
|
2023
Q4 | $25.6M | Buy |
|
|||||
|
2023
Q3 | $10.4M | Sell |
|
|||||
|
2023
Q2 | $14M | Buy |
|
|||||
|
2023
Q1 | $6.35M | Sell |
|
|||||
|
2022
Q4 | $7.83M | Sell |
|
|||||
|
2022
Q3 | $11.1M | Sell |
|
|||||
|
2022
Q2 | $12.7M | Sell |
|
|||||
|
2022
Q1 | $21.3M | Buy |
|
|||||
|
2021
Q4 | $25.7M | Buy |
|
|||||
|
2021
Q3 | $37.5M | Buy |
|
|||||
|
2021
Q2 | $45.8M | Sell |
|
|||||
|
2021
Q1 | $40.6M | Buy |
|
|||||
|
2020
Q4 | $58.5M | Sell |
|
|||||
|
2020
Q3 | $30.2M | Buy |
|
|||||
|
2020
Q2 | $29.3M | Buy |
|
|||||
|
2020
Q1 | $15.1M | Sell |
|
|||||
|
2019
Q4 | $33.4M | Buy |
|
|||||
|
2019
Q3 | $23.8M | Buy |
|
|||||
|
2019
Q2 | $21M | Sell |
|
|||||
|
2019
Q1 | $45.9M | Sell |
|
|||||
|
2018
Q4 | $43.2M | Buy |
|
|||||
|
2018
Q3 | $55.1M | Sell |
|
|||||
|
2018
Q2 | $74.1M | Buy |
|
|||||
|
2018
Q1 | $62.4M | Buy |
|
|||||
|
2017
Q4 | $19.1M | Buy |
|
|||||
|
2017
Q3 | $13.5M | Buy |
|
|||||
|
2017
Q2 | $7.75M | Buy |
|
|||||
|
2017
Q1 | $6.89M | Buy |
|
|||||
|
2016
Q4 | $3.38M | Sell |
|
|||||
|
2016
Q3 | $3.4M | Sell |
|
|||||
|
2016
Q2 | $7.28M | Buy |
|
|||||
|
2016
Q1 | $4.93M | Buy |
|